Stem cells: the blue print for the future.
The investment going into stem-cell therapies and technologies is impressive. The objectives are great, including the aim of tissues on demand within 20 years, and the rewards potentially huge with a suggested annual market of US dollar 500 billion. This article outlines current activities on both sides of the Atlantic.
Mason
Chris
C
Advanced Centre for Biochemical Engineering, University College London, UK. chris.mason@ucl.ac.uk
D001709:Biotechnology / Q000191:economics* / Q000639:trends; D033041:Embryo Research / Q000191:economics*; D005544:Forecasting; D019981:Health Care Sector / Q000639:trends*; D006301:Health Services Needs and Demand / Q000639:trends; D006801:Humans; D007449:Investments; D012038:Regeneration; D033581:Stem Cell Transplantation / Q000191:economics / Q000639:trends*; D013234:Stem Cells / Q000166:cytology*; D006113:United Kingdom; D014481:United States